Pacific Biosciences of California, Inc. (PACB) saw its loss widen to $23.87 million, or $0.26 a share for the quarter ended Mar. 31, 2017. In the previous year period, the company reported a loss of $19.35 million, or $0.23 a share. Revenue during the quarter surged 30.26 percent to $24.92 million from $19.13 million in the previous year period. Gross margin for the quarter contracted 1382 basis points over the previous year period to 35.87 percent. Operating margin for the quarter stood at negative 93.51 percent as compared to a negative 97.06 percent for the previous year period.
Operating loss for the quarter was $23.30 million, compared with an operating loss of $18.56 million in the previous year period.
Disclaimer: Please note that this is an auto-generated article. IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website. For queries contact: [email protected]